23andMe
-
23andMe Adds Health Community Page on HCM
May 21
23andMe announced that 23andMe Health + Ancestry Service customers can access a new Health Community page focused on hypertrophic cardiomyopathy (HCM), the most common form of inherited heart disease. The new HCM Health Community page offers customers information and resources on this condition, which in most cases is caused by geneti...
-
23andMe Genetic Risk Report for TTR-Related Amyloidosis
Apr 18
23andMe added a new Genetic Health Risk report on TTR-related hereditary amyloidosis. It is a genetic, multi-system disease. Transthyretin amyloidosis is a slowly progressive condition characterized by the buildup of abnormal deposits of a protein called amyloid (amyloidosis) in the body's organs and tissues. These protein deposits most fre...
-
23andMe Tests New Ancestry Breakdown in Central and South Asia
Apr 11
23andMe is testing an extensive update to their Ancestry Composition feature that dramatically improved results for 23andMe customers with Central and South Asian ancestry. More specifically, this update will benefit those with ancestry from Afghanistan, Pakistan, India, Bangladesh, Sri Lanka, or Nepal. The new ancestry breakdown in Central and ...
-
23andMe Offers Genetic Report on Type 2 Diabetes
Mar 26
23andMe has a new Type 2 Diabetes report that offers customers insight into their likelihood of developing one of the most prevalent, pernicious, and preventable health conditions in the United States. 23andMe hopes that the Type 2 Diabetes report will help raise awareness about diabetes, as well as the potential to make healthy lifestyle chang...
-
The New York Times and 23andMe Disagree
Feb 14
The Editorial Board of The New York Times posted an opinion piece titled: “Why You Should Be Careful About 23andMe's Health Test”. In response, 23andMe posted a letter to the editor titled: “23andMe Responds: Empowering Consumers”. The two disagree about the accuracy of 23andMe's genetic tests results. The New York Times Editorial Board...
-
23andMe Explains Why Diversity Matters in Genetic Research
Feb 5
23andMe posted an informative blog that explains why diversity matters in research. Improving diversity and inclusion of underrepresented populations in research doesn't just benefit those groups. It benefits everyone. Africans and African Americans are among the most underrepresented populations in genetic health research, yet they face the mos...
-
Study: Genetics May Nudge Some People Toward Risky Behavior
Jan 15
A study done by researchers from the Social Science Genetic Association Consortium (SSGAC) suggests that genetics may nudge some individuals toward more risky behavior like smoking, drinking and speeding. The study, which was published in the journal Nature Genetics, included data from more than a million people. The researchers identified 124 g...
-
23andMe Works Toward Improving Diversity in Genetic Research
Dec 5
23andMe has put in effort toward improving diversity in its genetic research. This includes their Global Genetics Project and their Populations Collaborations Program. The goal is not only to help diversify 23andMe's research database, but also to drive inclusion of understudied populations. 23andMe points out that currently, more than 90 percen...
-
23andMe Provides Information About Breast Cancer Genes
Oct 11
October is Breast Cancer Awareness Month. Certain types of breast cancer can run in families. 23andMe offers the first and only FDA-authorized, direct-to-consumer BRCA genetic health risk report. This test focuses on three specific variants of the BRCA1 and BRCA2 genes. 23andMe offers a genetic test for three variants of the BRCA1 and BRCA2 gen...
-
Which DNA Company Gives You a Bigger Bang for the Buck?
Aug 21
Genealogists who have decided to explore the information that is hidden in their genes face a dilemma. Which DNA testing company should they choose? Which one can give them a bigger bang for the buck? It all depends on what you are hoping to learn from your DNA results. Here are a few to consider: AncestryDNA * Regular Price: $99 * More tha...